celastrol has been researched along with HIV Coinfection in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dubrulle, J; Hu, PW; Liu, H; Mancini, MA; Nikolai, BC; Rice, AP; Stossi, F | 1 |
1 other study(ies) available for celastrol and HIV Coinfection
| Article | Year |
|---|---|
Identification of celastrol as a novel HIV-1 latency reversal agent by an image-based screen.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Cells, Cultured; Drug Discovery; HIV Infections; HIV-1; Humans; Jurkat Cells; Pentacyclic Triterpenes; Virus Latency | 2021 |